Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase 1

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

lomibuvir (VX 222) / Trek Therapeutics

NCT00958152: Drug-Drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects

Completed

RoW

VCH-222, telaprevir

Vertex Pharmaceuticals Incorporated

Hepatitis C

01/10

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites